Debates over drug patents are increasingly driven by slogans rather than substance. Claims of “evergreening,” “patent thickets,” and abusive exclusivity are routinely invoked to justify policy ...
Emilio Berkenwald of Berken IP details the unique declaration requirements and benefits for inventors navigating disclosure and intellectual property protection under Argentina’s patent law framework ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results